Physician Scientist - Oncology

Egorin, Merrill J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Institutional National Research Service Award (T32)
• Project #: 5T32CA009633-05
• Application #: 2085725
• Study Section: Cancer Institutional Fellowship Review Committee (CT)
• Project Start: 1989-09-01
• Project End: 1994-10-31
• Budget Start: 1993-05-01
• Budget End: 1994-10-31
• Support Year: 5
• Fiscal Year: 1993

Institution

• Name: University of Maryland Baltimore
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 003255213
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21201

Publications

Meltzer, S J; O'Doherty, S P; Frantz, C N et al. (1996) Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma. Br J Cancer 74:1855-61

Lenehan, P F; Gutierrez, P L; Wagner, J L et al. (1995) Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells. Cancer Chemother Pharmacol 35:377-86

Huslig, R L; Mishra, S; Hamburger, A W (1993) Interferon-enhancement of tyrosine phosphorylation of epidermal growth factor receptors in human breast carcinoma cells. Anticancer Res 13:613-7